Toxicology of Psychoactive Substances

被引：4
|
作者：
Prisco, Lara [1 ,2 ]
Sarwal, Aarti [3 ]
Ganau, Mario [4 ]
Rubulotta, Francesca [5 ,6 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Neurosci Intens Care Unit, Level 1 West Wing,Headley Way, Oxford OX3 9DU, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Level 6 West Wing,Headley Way, Oxford OX3 9DU, England
[3] Wake Forest Baptist Med Ctr, Neurocrit Care Unit, Med Ctr Blvd, Winston Salem, NC 27157 USA
[4] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Neurosci Dept, Level 2 West Wing,Headley Way, Oxford OX3 9DU, England
[5] McGill Univ, Dept Anesthesia, Crit Care Program, 845 Sherbrooke St W, Montreal, PQ H3A 0G4, Canada
[6] Imperial Coll NHS Trust, Charing Cross Hosp, Dept Anesthesiol & Intens Care Med, Hlth Ctr,Intens Care Unit, Fulham Palace Rd, London W6 8RF, England
来源：
CRITICAL CARE CLINICS | 2021年 / 37卷 / 03期
关键词：
Psychoactive substances; Antidepressants; Selective serotonin reuptake inhibitors; antipsychotics; Mood stabilizers; Hallucinogens; NEUROLEPTIC MALIGNANT SYNDROME; CONSENSUS GUIDELINE; CLINICAL TOXICOLOGY; SEROTONIN SYNDROME; ANTIDEPRESSANT; MANAGEMENT; LITHIUM; PHARMACOLOGY; ASSOCIATION; TOXICITY;
D O I：
10.1016/j.ccc.2021.03.013
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：517 / 541
页数：25
相关论文
共 50 条
  • [1] Clinical toxicology of the new psychoactive substances
    Dargan, P. I.
    [J]. TOXICOLOGY LETTERS, 2016, 259 : S46 - S46
  • [2] An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
    Chiappini, Stefania
    Schifano, Fabrizio
    [J]. PHARMACEUTICALS, 2023, 16 (08)
  • [3] New psychoactive substances in the context of postmortem toxicology
    Kraemer, M.
    Maas, A.
    Madea, B.
    [J]. RECHTSMEDIZIN, 2019, 29 (01) : 51 - 63
  • [4] The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines
    Tyrkko, Elli
    Andersson, Mikael
    Kronstrand, Robert
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (02) : 190 - 216
  • [5] Novel psychoactive substances: Findings in a regional toxicology center in 2014
    Mueller, Dieter
    Neurath, Hartmud
    Just, Simone
    Liebetrau, Gesine
    Desel, Herbert
    [J]. CLINICAL TOXICOLOGY, 2015, 53 (04) : 363 - 363
  • [6] TOXICOLOGY OF NEW PSYCHOACTIVE SUBSTANCES: AN INTERNATIONAL SURVEY ON THE EXPOSURE TO DRUG USE
    Anghel, Daniela-Madalina Ciuca
    Stan, Miriana
    Balalau, Cristian
    Tudor, Gheorghe
    Baconi, Daniela Luiza
    [J]. FARMACIA, 2022, 70 (03) : 425 - 433
  • [7] New challenges and innovation in forensic toxicology: Focus on the "New Psychoactive Substances"
    Favretto, Donata
    Pascali, Jennifer P.
    Tagliaro, Franco
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2013, 1287 : 84 - 95
  • [8] New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
    Wagmann, Lea
    Jacobs, Cathy M.
    Meyer, Markus R.
    [J]. THERAPEUTIC DRUG MONITORING, 2022, 44 (05) : 599 - 605
  • [9] Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health
    Huestis, Marilyn A.
    Brandt, Simon D.
    Rana, Suman
    Auaewrter, Volker
    Baumann, Michael H.
    [J]. CLINICAL CHEMISTRY, 2017, 63 (10) : 1564 - 1569
  • [10] Behavioural toxicology and metabolomics of novel psychoactive substances (NPS) in controlled human studies
    Ramaekers, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S541 - S542
12345